A Study of Ponesimod in Healthy Adult Participants
Clinical trial NCT05552196 · COMPLETED
Trial details
- NCT number
- NCT05552196
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2023-03-05
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.